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GREENAWAY, JR., Circuit Judge. 
 
 Plaintiffs, Gerard Kenney, Alexa Joshua, Glen Dela Cruz Manalo, and Katherine 
Murray Leisure, physicians with specialties in internal medicine, brought suit against the 
American Board of Internal Medicine (ABIM) alleging violations of Sections 1 and 2 of 
the Sherman Act, the Racketeer Influenced and Corrupt Organizations Act (RICO), and a 
claim for unjust enrichment.  The gravamen of their complaint is that ABIM forces 
internists who purchase an initial certification to also purchase ABIM’s maintenance of 
certification product.  The District Court dismissed all of Plaintiffs’ claims.  We will 
affirm.   
I. Background 
A. ABIM, Certifications, and MOC 
ABIM is a non-profit organization led by a board of physicians and is a member of 
the American Board of Medical Specialties (ABMS), which is comprised of twenty-four 
medical boards that certify physicians in certain specialties and subspecialties.  ABIM 
began offering a certification in 1936.  No state medical licensing board requires a 
 
* This disposition is not an opinion of the full Court and pursuant to I.O.P. 5.7 does not 




physician to be certified by ABIM to be licensed to practice internal medicine within that 
state.   
Initially, ABIM offered lifetime certifications that did not require physicians to 
take additional examinations or complete other requirements to maintain the certification.  
In the 1970s, ABIM introduced a program called Continuous Professional Development 
(CPD), which included a voluntary examination.   
In 1990, ABIM began to offer time-limited certifications, which required internists 
to pass a mandatory examination and complete other requirements every ten years to 
maintain their ABIM certification.  This program of additional requirements and an 
examination is generally known as maintenance of certification (MOC).  Internists who 
were certified prior to 1990 were “grandfathered” in and were not required to participate 
in MOC to maintain their certifications.   
MOC requirements have changed over time, and in 2018, ABIM modified MOC 
to its current form.  Today, ABIM-certified internists are required to pay an annual 
program fee as well as an “assessment fee” for MOC examinations.  In addition, 
internists who participate in MOC have the option of either taking a test every two years 
or taking a must-pass examination every ten years.  An internist who was initially 
certified in 1990 or after but does not complete the requisite MOC is listed on the ABIM 
website as “Not Certified.”  Internists who were certified by ABIM prior to 1990 
continue to be grandfathered in and are not required to participate in MOC to maintain 




Plaintiffs allege that the National Board of Physicians and Surgeons (NBPAS) is a 
competitor of ABIM in the market for maintenance of certification.  NBPAS was 
established in 2015 and provides MOC-type products to physicians practicing in a variety 
of specialties, including internal medicine.  NBPAS does not offer an initial certification 
in internal medicine or any other specialty.  To obtain a MOC-type product from NBPAS, 
a physician must:  (1) hold a certification from an ABMS member board, (2) hold a valid 
state license to practice medicine, and (3) have completed a certain number of hours of 
continuing medical education (CME).  NBPAS’s fees for its MOC-type products are 
lower than ABIM’s MOC fees, and NBPAS’s MOC-type products require less of a 
physician’s time than ABIM’s MOC.   
C. Plaintiffs 
Dr. Kenney was initially certified by ABIM in 1993 and obtained a 
gastroenterology subspecialty certification in 1995.  In 2007, Dr. Kenney passed a 
required MOC examination.  Later, Dr. Kenney decided to not take the MOC 
examination again, which resulted in his subspecialty certification expiring on 
December 31, 2017.  In late 2017, while employed in private practice, Dr. Kenney 
received an offer of employment from another practice group.  This potential employer 
required Dr. Kenney to maintain his ABIM certification.  Dr. Kenney ultimately decided 
to decline the offer of employment because of the complications arising from complying 
with the requirement to maintain his ABIM certification.   
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 Dr. Joshua was certified by ABIM in internal medicine in 2003.  In 2009, one of 
Dr. Joshua’s employers mandated that physicians had to maintain their certifications from 
medical boards that issued time-limited certifications.  Dr. Joshua did not pass a MOC 
examination in 2014, and therefore, her certification in internal medicine was terminated.  
Two years later, an insurance company informed Dr. Joshua that it would no longer cover 
her because it required her to be certified by ABIM.  In December 2017, Dr. Joshua’s 
privileges at a hospital expired because of her lapsed ABIM certification, and she was 
limited to providing only outpatient care to that hospital’s patients.   
 Dr. Manalo was initially certified by ABIM in 1997, and he received a 
gastroenterology subspecialty certification in 2000.  Dr. Manalo decided not to purchase 
MOC; therefore, his internal medicine certification was terminated in 2007 and his 
subspecialty certification was terminated in December 2010.  Dr. Manalo’s employer 
informed him that he would lose staff privileges unless his certifications were 
maintained, as required by the bylaws of the organization.  Dr. Manalo offered to take 
CME courses in lieu of MOC and maintain the certifications, but his employer rejected 
this alternative.  Dr. Manalo’s employment was terminated in December 2010 because of 
his lapsed ABIM certifications.  Dr. Manalo secured employment in April 2011 and 
remained with that employer until April 2017.  Dr. Manalo has been unemployed since 
2017 with prospective employers informing him that “they only recognized ABIM 
certification and MOC.”  Am. Compl. ¶ 101.   
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 Dr. Murray-Leisure obtained an internal medicine certification from ABIM in 
1984.  She obtained an infectious disease subspecialty certification from ABIM in 1990 
and purchased MOC to maintain that certification in 2000 and 2010.  In 2010, Dr. 
Murray-Leisure moved to Massachusetts and began working at a hospital that required 
physicians with staff privileges, like her, to maintain ABIM certifications in their 
subspecialties.  Dr. Murray-Leisure’s subspecialty certification was terminated as a result 
of her not passing the required examination.  This resulted in the hospital revoking her 
infectious diseases privileges.  In 2012, Dr. Murray-Leisure passed the MOC examination 
resulting in her subspecialty certification and privileges being reinstated.   
D. Plaintiffs’ RICO Allegations  
In support of their RICO claim, Plaintiffs allege that ABIM “knowingly made 
fraudulent, false, and misleading statements of fact about MOC to the public.”  Id. ¶ 133.  
These include a statement in a 1999 ABIM newsletter that “the current certification 
process and the new evolving recertification initiative which is dedicated to continued 
professional development serve those needs and produce a reliable indicator of physician 
quality.”  Id. ¶ 134.  Plaintiffs allege that because the statement was made before the first 
MOC examination was administered, it was impossible for ABIM to know whether MOC 
would be “a reliable indicator of physician quality.”  Id.  Plaintiffs also allege that certain 
statements on ABIM’s website are fraudulent, false, and misleading.   
Plaintiffs allege that statements made by ABIM’s former President and a former 
member of the ABIM Board of Directors regarding MOC constituting “self-regulation” 
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are actionable.  Per Plaintiffs, MOC does not constitute self-regulation because (1) not 
meeting MOC requirements does not result in a loss or suspension of licensure—state 
medical boards are “the only relevant self-regulatory bodies[,]” and (2) ABIM is not a 
“self-regulatory” body because it lacks accountability as it is not subject to oversight.  Id. 
¶¶ 155–56.   
 The District Court dismissed all of Plaintiffs’ claims.  Specifically, the District 
Court found that Plaintiffs’ failure to plausibly allege that “ABIM’s initial certification 
and MOC products . . . occupy distinct markets” was fatal to the Section 1 claim, which 
was dismissed with prejudice.  Kenney v. Am. Bd. of Internal Med., 412 F. Supp. 3d 530, 
545 (E.D. Pa. 2019).  As to the Section 2 claim, the District Court concluded that ABIM 
could not have monopoly power in the MOC market because no such market exists.  Id. 
at 548.  The District Court also addressed two allegations related to an “overall 
certification market” and found those allegations were insufficient to sustain Plaintiffs’ 
Section 2 claim, which was dismissed without prejudice.  Id. at 548–49.  Plaintiffs’ RICO 
claims were also dismissed without prejudice because the District Court found that 
“ABIM’s alleged fraudulent statements [were] too attenuated” from the many reasons 
that Plaintiffs’ employers may have required Plaintiffs to hold an ABIM certification “to 
substantiate a claim.”  Id. at 551.  The District Court dismissed the unjust enrichment 
claim with prejudice because the District Court found that it would not be inequitable for 
ABIM to retain the benefits it received from Plaintiffs as ABIM had not forced Plaintiffs 
to purchase MOC.  Plaintiffs did not amend their complaint to replead the Section 2 and 
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RICO claims, and the District Court entered a final judgment and order against Plaintiffs.  
This appeal followed. 
II. Jurisdiction and Standard of Review 
The District Court had subject matter jurisdiction over the Sherman Act and RICO 
claims pursuant to 28 U.S.C. §§ 1331 and 1337, and supplemental jurisdiction over the 
unjust enrichment claim pursuant to 28 U.S.C. § 1367.  We have jurisdiction pursuant to 
28 U.S.C. § 1291. 
We exercise plenary review over a district court’s grant of a motion to dismiss 
pursuant to Federal Rule of Civil Procedure 12(b)(6).  St. Luke’s Health Network, Inc. v. 
Lancaster Gen. Hosp., 967 F.3d 295, 299 (3d Cir. 2020).  “[I]n deciding a motion to 
dismiss, all well-pleaded allegations of the complaint must be taken as true and 
interpreted in the light most favorable to the plaintiffs, and all inferences must be drawn 
in favor of them.”  McTernan v. City of York, 577 F.3d 521, 526 (3d Cir. 2009) (internal 
quotation marks and citation omitted).  To withstand a Rule 12(b)(6) “motion to dismiss, 
a complaint must contain sufficient factual matter, accepted as true, to state a claim to 
relief that is plausible on its face.”  Ashcroft v. Iqbal, 556 U.S. 662, 678 (2009) (internal 
quotation marks and citation omitted). 
III. Discussion 
A. Plaintiffs’ Section 1 Tying Claims   
Section 1 of the Sherman Act provides, in relevant part, that “[e]very contract, 
combination in the form of trust or otherwise, or conspiracy, in restraint of trade or 
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commerce among the several States, or with foreign nations, is declared to be illegal.”  15 
U.S.C. § 1.  A tying arrangement that violates Section 1 is “an agreement by a party to 
sell one product but only on the condition that the buyer also purchases a different (or 
tied) product, or at least agrees that he will not purchase that product from any other 
supplier.”  N. Pac. Ry. Co. v. United States, 356 U.S. 1, 5–6 (1958); Warren Gen. Hosp. 
v. Amgen Inc., 643 F.3d 77, 80 (3d Cir. 2011) (quoting Gordon v. Lewistown Hosp., 423 
F.3d 184, 213 (3d Cir. 2005)) (“Tying is selling one good (the tying product) on the 
condition that the buyer also purchase another, separate good (the tied product).”).  
The elements of a per se tying claim are satisfied “where (1) a defendant seller ties 
two distinct products; (2) the seller possesses market power in the tying product market; 
and (3) a substantial amount of interstate commerce is affected . . . .”  Town Sound & 
Custom Tops, Inc. v. Chrysler Motors Corp., 959 F.2d 468, 477 (3d Cir. 1992); 
Brokerage Concepts, Inc. v. U.S. Healthcare, Inc., 140 F.3d 494, 512–13 (3d Cir. 1998).  
A rule of reason tying claim requires a showing that the alleged tie “unreasonably 
restrained competition[,]” which “necessarily involves an inquiry into the actual effect of 
the [challenged conduct] on competition [in the tied market].”  Brokerage Concepts, 140 
F.3d at 519 (quoting Jefferson Par. Hosp. Dist. No. 2 v. Hyde, 466 U.S. 2, 29 (1984)).   
 The District Court did not consider each element of the per se tying claim as it 
concluded that the claim failed on the first element.  See Kenney, 412 F. Supp. 3d at 547.  
Plaintiffs object to the District Court’s finding, arguing that they have “alleged facts 
showing certifications and MOC are separate products and have also alleged all other 
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elements of a per se tying claim.”  Appellants’ Br. 24.  We disagree with Plaintiffs and, 
like the District Court, confine our analysis to whether Plaintiffs have plausibly alleged 
that ABIM’s initial certifications and MOC are separate products.   
 “[T]he answer to the question whether one or two products are involved turns not 
on the functional relation between them, but rather on the character of the demand for the 
two items.”  Jefferson Par., 466 U.S. at 19.  “[A] tying arrangement cannot exist unless 
there is a sufficient demand for the purchase of the tied product separate from the 
purchase of the tying product so as to identify a market structure in which it is efficient to 
offer the tied product separately from the tying product.”  Allen-Myland, Inc. v. Int’l Bus. 
Machines Corp., 33 F.3d 194, 211 (3d Cir. 1994).   
 Plaintiffs contend that Jefferson Parish and Eastman Kodak Co. v. Image 
Technical Services, Inc., 504 U.S. 451 (1992), set forth “factual indicia of separate 
demand governing the separate product analysis,” and that their complaint contains 
“alleged facts supporting each such indicia.”  Appellants’ Br. 12, 17.  Specifically, 
Plaintiffs aver that “[1] internists differentiate between certifications and MOC; 
[2] ABIM has always sold them separately; [3] ABIM treats the two products as separate; 
[4] ABIM bills and accounts for certifications and MOC separately; and [5] other vendors 
sell CPD products like MOC that keep internists current without selling certifications.”  
Id. at 12. 
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However, whether considered individually or collectively, these alleged indicia do 
not support a conclusion that Plaintiffs have plausibly alleged that ABIM’s initial 
certification and MOC are separate products.  
 Consumer Differentiation   
 Plaintiffs first contend that they have alleged that “consumers (internists) 
differentiate between certification and MOC[,]” and support this proposition with 
citations to paragraphs of the Amended Complaint.  Appellants’ Br. 25.  These 
paragraphs, however, do not bear the weight of Plaintiffs’ contention.   
For example, Plaintiffs cite paragraphs 55 and 66 to support the proposition that 
“internists prefer to purchase CPD products like MOC separate from certifications.”  Id.  
These paragraphs simply allege that “[i]nternists have a desire to obtain maintenance of 
certification from providers other than ABIM,” Am. Compl. ¶ 55, and that “[n]umerous 
board certified internists do not want to be required to buy ABIM’s MOC and/or would 
seek maintenance of certification from a source other than ABIM[,]” id. ¶ 66.  Neither 
allegation sheds light on whether there is consumer demand to purchase ABIM’s MOC 
product because the Court must infer that the products are sufficiently similar such that 
consumer demand for products other than ABIM’s MOC reflects consumer demand for 
ABIM’s MOC.  The Court cannot draw that inference given Plaintiffs’ allegations 
regarding material differences between ABIM’s MOC and other products.  See id. ¶¶ 32–
35, 57, 59.  Given the alleged differences between the products, the demand for products 
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other than ABIM’s MOC appears to be irrelevant to the Court’s analysis of whether there 
is separate demand for ABIM’s MOC and initial certifications.1 
 Plaintiffs also support their differentiation argument by contending that ABIM’s 
grandfathering of internists who were certified prior to 1990 is “[e]specially probative.”  
Appellants’ Br. 26.  Plaintiffs, however, do not explain how this allegation is probative of 
consumer demand for MOC and initial certification.2  The obvious inference the Court 
can draw from this allegation is that the purchase of a lifelong certification is evidence of 
demand for that product.  This inference, however, does not support Plaintiffs’ separate 
demand argument because demand for lifelong certifications does not equal separate 
demand for time-limited certifications or MOC, especially in light of Plaintiffs’ argument 
that ABIM’s MOC is not a component of a single product.  Appellants’ Br. 30.  
 Selling Initial Certifications and MOC Separately 
Relying on Kodak and Multistate Legal Studies, Inc. v. Harcourt Brace 
Jovanovich Legal & Professional Publications, Inc., 63 F.3d 1540 (10th Cir. 1995), 
 
1 Plaintiffs also argue that internists’ purchase of “CPD products from CME vendors for 
state licensure purposes” is confirmation of consumer differentiation.  Appellants’ Br. 26.  
This argument is unavailing for the reasons discussed above.  Similarly, Plaintiffs’ 
argument that “[o]ther vendors sell CPD products without selling certifications” is a 
supply-side version of the same unpersuasive argument.  Appellants’ Br. 37.   
 
2 On reply, Plaintiffs provide a lengthy explication of the probative value of ABIM’s 
grandfathering policy.  Appellants’ Reply 19–20.  However, “arguments raised in 
passing . . . but not squarely argued, are considered [forfeited].”  John Wyeth & Bro. Ltd. 
v. CIGNA Int’l Corp., 119 F.3d 1070, 1076 n.6 (3d Cir. 1997); see also In re Wettach, 
811 F.3d 99, 115 (3d Cir. 2016) (holding that arguments not developed in an appellant’s 
opening brief are forfeited).   
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Plaintiffs suggest that the sale of initial certifications and MOC separately is evidence of 
separate demand.  Plaintiffs’ reliance on those cases, however, elides a critical difference 
between the products and services at issue in those cases and those at issue in the instant 
matter: the efforts required to secure an initial certification and MOC.  Plaintiffs allege 
that to secure an ABIM initial certification, an individual must be a physician who has 
completed “intensive study, self-assessment and evaluation” in addition to training in 
internal medicine.  Am. Compl. ¶ 21.  ABIM’s MOC, similarly, requires physicians to 
complete a number of activities including: a regular MOC Activity, patient safety and 
survey programs, physician self-evaluations, as well as taking and passing examinations.  
Thus, initial certifications and MOC are earned and reflect a physician’s initial training 
and his or her “staying current with knowledge and practice in his[ or ]her discipline.”  
Am. Compl. ¶ 53.  Thus, the context in which initial certifications and MOC are 
purchased is not the same as the consumer and commercial transactions involving the 
products and services at issue in Kodak and Multistate Legal.3  As a result, the fact that 
the products at issue in this matter are purchased in separate transactions (at disparate 
 
3 At issue in Kodak was (1) parts for complex business machines and (2) service for the 
same machines.  Kodak, 504 U.S. at 459.  At issue in Multistate was (1) “full-service” 
courses designed to prepare students for all aspects of state’s bar exam and 
(2) “supplemental multistate workshops” to prepare students for only a portion of a 




times, often years apart) provides far less support for the conclusion that there is separate 
demand for each product as the Supreme Court concluded in Kodak.4   
 ABIM’s Treatment of Initial Certifications and MOC  
Plaintiffs argue that statements contained in ABIM’s Internal Revenue Service 
filings and ABIM’s grandfathering policy establish that ABIM treats initial certification 
and MOC as separate products.  Plaintiffs allege that ABIM describes initial certifications 
as “demonstrat[ing] that physicians have completed internal medicine and subspecialty 
training and have met rigorous standards through intensive study, self-assessment” while 
MOC ‘“means something different from initial certification’ and ‘speaks to the question 
of whether or not an internist is staying current with knowledge and practice in his/her 
discipline[.]”’  Am. Compl. ¶¶ 21, 53.  Interpreting these statements to stand for the 
proposition that initial certifications and MOC are separate products inappropriately 
divorces them from the reality that ABIM initially certifies a physician in recognition of 
their training and skills at one point in time and successful completion of MOC 
requirements allows a physician to continue to hold themselves out as certified by ABIM 
 
4 Plaintiffs’ heavy reliance on Multistate Legal is misplaced.  In that case, the Tenth 
Circuit cited eight categories of evidence regarding whether the products at issue were 
separate products and the fact that the products were sold separately was only one of the 
eight categories identified and was not dispositive.  63 F.3d at 1547–48.  The Tenth 
Circuit did not analyze this evidence; rather, it concluded that the evidence was sufficient 
to create a material factual dispute as to consumer demand, which required remand to the 
district court for resolution.  Id. at 1548.  Here, the Court must decide whether Plaintiffs 
have plausibly alleged separate demand for two products and the Court need not accept 
Plaintiffs’ legal conclusions.     
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at a later point in time.  Thus, the factual statement that initial certifications and MOC are 
“different” does not establish that there is separate demand for each.   
Relying on the Jefferson Parish Court’s discussion of the defendant’s billing 
practices, Plaintiffs argue that ABIM’s billing and accounting of initial certifications and 
MOC is an indicator of separate demand.5  Jefferson Parish provides no support for 
Plaintiffs’ billing-related argument.  A close reading of the discussion upon which 
Plaintiffs rely reveals that the point being made by the Supreme Court was that while the 
hospital bundled the anesthesiologic services with other services in one package to its 
patients (i.e., insisting that its patients purchase anesthesiological services from the 
hospital’s designated provider), the hospital, “[a]s a matter of actual practice,” billed 
anesthesiological services separately from the other of services it provided.  Jefferson 
Par., 466 U.S. at 22.   
Here, ABIM does not offer a bundle of services from which MOC is billed 
separately.  Instead, initial certifications and MOC are purchased separately, often years 
apart.  The fact that these purchases are years apart could lead to a conclusion that initial 
certifications and MOC are separate products.  That conclusion, however, would be 
facile.  Plaintiffs allege that ABIM represents that MOC is structured to reflect a 
physician’s continuing expertise (over the decade after initial certification) and ultimately 
 
5 Plaintiffs do not explain how ABIM’s internal accounting practices are relevant to the 
separate products analysis.  Even if Plaintiffs had made an argument on this point, it 
would have likely failed because ABIM’s internal accounting practices neither provide 
any information nor allow the Court to draw any interferences about the character of 
consumer demand for initial certifications and MOC.   
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reflects the same thing that initial certification represents—that the physician presently 
meets ABIM’s standard for certification.  Thus, the relationship between initial 
certifications and MOC is vastly different than the relationship between anesthesiological 
services and healthcare services, which were delivered at the same time and billed 
separately, that were at issue in Jefferson Parish.   
In sum, when viewed on their own, none of the allegations that Plaintiffs identify 
as factual indicia of separate demand allow the Court to conclude that Plaintiffs have 
plausibly alleged that there is separate demand for initial certifications and MOC.  When 
viewed in combination, the indicia fare no better.  As a result, we conclude that Plaintiffs 
failed to plausibly allege the first element of a per se tying claim—the tying of two 
distinct products.  The failure to plausibly allege separate products is also fatal to 
Plaintiffs’ rule of reason tying claim.6  See Brokerage Concepts, 140 F.3d at 511 (when 
bringing a rule of reason tying claim, the plaintiff has the burden of showing the tie 
“unreasonably restrained competition in the tied product market”).   
B. Plaintiffs’ Section 2 Claim 
Section 2 of the Sherman Act targets “[e]very person who shall monopolize, or 
attempt to monopolize, or combine or conspire with any other person or persons, to 
monopolize any part of the trade or commerce among the several States, or with foreign 
nations . . . .”  15 U.S.C. § 2.  A Section 2 claim has two elements:  “(1) the possession of 
 
6 While the District Court did not consider Plaintiffs’ rule of reason tying claim, we need 
not remand to the District Court for consideration of that claim.   
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monopoly power in the relevant market and (2) the willful acquisition or maintenance of 
that power as distinguished from growth or development as a consequence of a superior 
product, business acumen, or historic accident.”  United States v. Grinnell Corp., 384 
U.S. 563, 570–71 (1966).   
The District Court dismissed Plaintiffs’ Section 2 monopolization claim, 
concluding that because MOC is not a separate product and there was no separate market, 
“ABIM cannot have a monopoly in a market that does not exist.”  Kenney, 412 F. Supp. 
3d at 548.  Plaintiffs concede that the relevant market for their Section 2 claim is the 
same MOC market for their Section 1 claim.  Given the Court’s conclusion that Plaintiffs 
have failed to plausibly allege that initial certifications and MOC are separate products, 
the Court also concludes that Plaintiffs have not plausibly alleged the existence of a MOC 
market, which is required to plausibly allege a Section 2 claim.  Therefore, we will affirm 
the District Court’s dismissal of Plaintiffs’ Section 2 claim.  
C. Plaintiffs’ RICO Claim 
Section 1964(c) of Title 18 of the United States Code provides a private right of 
action for “[a]ny person injured in his business or property by reason of a violation of 
section 1962,” which provides, in pertinent part, that it is “unlawful for any person 
employed by or associated with any enterprise engaged in, or the activities of which 
affect, interstate or foreign commerce, to conduct or participate, directly or indirectly, in 
the conduct of such enterprise’s affairs through a pattern of racketeering activity . . . .”  
18 U.S.C. § 1962(c).  A plaintiff bringing a RICO claim must have Article III standing 
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and “state an injury to business or property and ‘that a RICO predicate offense not only 
was a but for’ cause of injury, but was the proximate cause as well.’”  St. Luke’s Health 
Network, Inc. v. Lancaster Gen. Hosp., 967 F.3d 295, 300 (3d Cir. 2020) (quoting Hemi 
Grp., LLC v. City of New York, 559 U.S. 1, 9 (2010)).   
The District Court dismissed Plaintiffs’ RICO claim, finding that Plaintiffs failed 
to plausibly allege that ABIM’s actions were the proximate cause of Plaintiffs’ alleged 
injuries.  Kenney, 412 F. Supp. 3d at 551 (finding that “ABIM’s alleged fraudulent 
statements [were] too attenuated [from the many reasons Plaintiffs’ employers may have 
required Plaintiffs to hold an ABIM certification] to substantiate a claim”).  Plaintiffs 
argue that the District Court “misapplied” binding precedent, because this is not a case 
where their injuries are “indirect and only derivative of” ABIM’s predicate acts.  
Appellants’ Br. at 61.  Rather, Plaintiffs and other internists are “the targets and 
‘immediate victims’ of ABIM’s RICO scheme[.]”  Id. at 62. 
Whether ABIM’s conduct is the proximate cause of Plaintiffs’ alleged injuries and 
whether the chain of causation is broken by the decisions of Plaintiffs’ employers and 
others are questions that the Court need not consider because we discern a more 
fundamental issue with Plaintiffs’ RICO-related allegations.  In its motion to dismiss, 
ABIM argued that Plaintiffs’ RICO claim was subject to dismissal for failure to comply 
with the particularity requirements of Federal Rule of Civil Procedure 9(b).  We agree 
with ABIM.  
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Rule 9(b) requires that when “alleging fraud or mistake, a party must state with 
particularity the circumstances constituting fraud or mistake.”  When a party relies on a 
violation of the mail and wire fraud statutes as a predicate offense for an alleged RICO 
violation, as Plaintiffs do here, the complaint must comply with Rule 9(b).  Lum v. Bank 
of Am., 361 F.3d 217, 223–24 (3d Cir. 2004).  Plaintiffs may satisfy this requirement by 
“pleading the ‘date, place or time’ of the fraud, or through ‘alternative means of injecting 
precision and some measure of substantiation into their allegations of fraud.’”  Id. at 224.  
In the context of a putative class action, prior to class certification, the complaint must be 
evaluated as to the named plaintiffs, and failure to plead with the requisite specificity as 
to the named plaintiffs is fatal to the plaintiffs’ claim.  See Rolo v. City Investing Co. 
Liquidating Tr., 155 F.3d 644, 657–59 (3d Cir. 1998). 
In Rolo, the plaintiffs alleged that certain defendants engaged in “a fraudulent 
marketing scheme to sell real estate[,]” which involved “lavish ‘investment seminars’ at 
which [a defendant] represented that the value of the real estate continually appreciated, 
that there was a good resale market for the lots and houses, and that the real estate was an 
excellent investment.”  Rolo, 155 F.3d at 648.  The scheme also involved allegedly 
fraudulent mailings.  Id. at 658–59.  The Court found that “the Complaint lack[ed] any 
specific allegations about the presentations made to any of the named plaintiffs” and did 
not include any specifics about seminars the named plaintiffs attended, “including who 
made the presentation, when it took place, or with reference to what property it was 
made.”  Id. at 658.  The same was true for the allegedly fraudulent mailings as they 
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lacked information about “when, by whom, and to whom a mailing was sent, and the 
precise content of each particular mailing [was] not detailed.”  Id. at 659.   
Here, Plaintiffs allege that ABIM made fraudulent, false, and misleading 
statements that fit into two categories:  (1) statements of fact about MOC and 
(2) statements that MOC constitutes self-regulation.  In the first category, Plaintiffs allege 
that in an ABIM newsletter dated Summer 1999, ABIM’s then-Chair stated that “the 
current certification process and the new evolving recertification initiative which is 
dedicated to continued professional development serve those needs and produce a reliable 
indicator of physician quality.”  Am. Compl. ¶ 134.  Plaintiffs also identify 
approximately six statements made by ABIM on its website as fitting into the first 
category of statements.  In the second category, Plaintiffs allege that in a 2012 article 
published in the New England Journal of Medicine, ABIM’s former president stated that 
“[t]he privilege of professional self-regulation is granted by society[,]” and this statement 
was in reference to MOC.  Id. ¶ 154.  Plaintiffs also allege, without providing the specific 
language used, that an individual who was no longer a member of the ABIM Board of 
Directors stated “in a 2017 Journal of the American Medical Association article that 
MOC constitutes self-regulation by the medical profession.”  Id. 
Plaintiffs failed to satisfy the particularity requirements of Rule 9(b).  Plaintiffs’ 
allegations regarding statements on the ABIM website are facially deficient for failing to 
identify the date and time of when the statements were made (i.e., when the statements 
were published on ABIM’s website).  Assuming that statements identified only by an 
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approximate time period of publication and the name of the publication in which the 
statements are made is sufficient to satisfy the date, time, and place requirement, 
Plaintiffs’ allegations are nonetheless deficient.  Plaintiffs do not allege that they 
individually read or heard these statements.  Nor do Plaintiffs allege that any of their 
employers or potentials employers read or heard these statements.   
Plaintiffs argued that they alleged that “third parties, hospitals, and insurance 
companies heard and believed those statements.”  Oral Arg. at 12:36–12:56.  Such broad 
allegations are in the Complaint.  Nevertheless, Rule 9(b) requires Plaintiffs to plead with 
more particularity than merely alleging misrepresentations were made to large swaths of 
the healthcare industry.  See Rolo, 155 F.3d at 659 (affirming dismissal of the plaintiffs’ 
RICO claim for failing to allege what actually happened to the named plaintiffs in 
relation to the alleged fraudulent statements).    
Because Plaintiffs failed to satisfy the particularity requirements of Rule 9, we will 
affirm the District Court’s dismissal of Plaintiffs’ RICO claim.  Watters v. Bd. of Sch. 
Dirs. of City of Scranton, 975 F.3d 406, 412 (3d Cir. 2020) (“[W]e may affirm based on 
any ground supported by the record.” (internal quotation marks and citation omitted)).   
D. Plaintiffs’ Unjust Enrichment Claim 
“The elements of unjust enrichment are [1]‘benefits conferred on defendant by 
plaintiff, [2] appreciation of such benefits by defendant, and [3] acceptance and retention 
of such benefits under such circumstances that it would be inequitable for defendant to 
retain the benefit without payment of value.’”  Styer v. Hugo, 619 A.2d 347, 350 (Pa. 
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Super. Ct. 1993) (quoting Wolf v. Wolf, 514 A.2d 901, 906 (Pa. Super. Ct. 1986)).  
Whether the doctrine of unjust enrichment applies “depends on the unique factual 
circumstances of each case,” and the Court does not focus “on the intention of the parties, 
but rather on whether the defendant has been unjustly enriched.”  Id.  A plaintiff bringing 
an unjust enrichment claim “must show that the party against whom recovery is sought 
either ‘wrongfully secured or passively received a benefit that it would be unconscionable 
for her to retain.’”  Torchia ex rel. Torchia v. Torchia, 499 A.2d 581, 582 (Pa. Super. Ct. 
1985) (quoting Roman Mosaic & Tile Co. v. Vollrath, 313 A.2d 305, 307 (Pa. Super. Ct. 
1973)). 
The District Court concluded that Plaintiffs failed to satisfy the third element of an 
unjust enrichment claim “because it is not inequitable for ABIM to keep the benefit since 
it did not ‘force’ Plaintiffs to purchase MOC.”  Kenney, 412 F. Supp. 3d at 552.  
Plaintiffs contend that the District Court erred because they sufficiently alleged that 
internists are forced to purchase MOC.  Appellants’ Br. 66.  Plaintiffs argue that they are 
“forced” to purchase MOC from ABIM because of the “economic reality” that if their 
ABIM certification is revoked, they “are no longer eligible for admitting and other 
privileges, employment, insurance coverage, and other requirements for the successful 
practice of medicine.”  Id.  Thus, internists are forced to purchase MOC, a product they 
do not want to buy.   
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Plaintiffs’ actions undermine their allegation that internists are forced to purchase 
MOC. 7  Dr. Kenney and Dr. Manalo were able to choose not to participate in MOC at 
certain points in their respective careers.  See Am. Compl. ¶¶ 79–80 (alleging that Dr. 
Kenney decided not to participate in MOC); id. ¶ 93 (“Dr. Manalo’s ABIM certification 
in internal medicine was terminated in 2007 after he decided not to purchase MOC.”).  
Dr. Manalo was able to secure employment and remain employed for six years despite 
his refusal to purchase MOC.  This suggests that he was able to resist the economic 
pressures that Plaintiffs allege force internists to purchase MOC.  Thus, Plaintiffs’ 
conclusory allegation that ABIM forces internists to purchase MOC, which the Court is 
not required to accept as true, is directly contradicted by Dr. Kenney’s and Dr. Manalo’s 
experiences with MOC.   
Ultimately, we conclude that Plaintiffs have not plausibly alleged that it would be 
inequitable for ABIM to retain the MOC-related fees paid by Drs. Kenney, Joshua, and 
Murray-Leisure because Plaintiffs have not plausibly alleged that they were forced to 
purchase MOC.  We, therefore, will affirm the District Court’s dismissal of the unjust 
enrichment claim.   
IV. Conclusion 
 For the foregoing reasons, we will affirm the District Court’s order.   
 
7 Plaintiffs do not allege that Dr. Manalo purchased MOC.  Thus, Dr. Manalo cannot 
bring an unjust enrichment claim based on MOC-related fees paid to ABIM because Dr. 
Manalo did not confer such a benefit on ABIM.   
